| Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL (NCT07778212) | The First Affiliated Hospital of Xiamen University | 2026-08-30 |
| Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer (NCT07753499) | The First Affiliated Hospital of Xiamen University | 2026-08-01 |
| Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL (NCT07749365) | The First Affiliated Hospital of Xiamen University | 2026-07-25 |
| DLL3-Targeted PET/CT in Small Cell Lung Cancer (NCT07677787) | The First Affiliated Hospital of Xiamen University | 2026-05-09 |
| GPC3-Targeted PET/CT in Hepatocellular Carcinoma (NCT07677774) | The First Affiliated Hospital of Xiamen University | 2026-05-01 |
| GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL (NCT06875063) | The First Affiliated Hospital of Xiamen University | 2026-04-30 |
| Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease (NCT07547930) | The First Affiliated Hospital of Xiamen University | 2026-04-24 |
| Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors (NCT07438093) | The First Affiliated Hospital of Xiamen University | 2026-04-01 |
| Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease (NCT07623382) | The First Affiliated Hospital of Xiamen University | 2026-03-31 |
| Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer (NCT07486492) | The First Affiliated Hospital of Xiamen University | 2026-03-31 |
| Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT06992739) | The First Affiliated Hospital of Xiamen University | 2025-12-08 |
| DLL3-Targeted PET/CT in Neuroendocrine Carcinoma (NCT07458906) | The First Affiliated Hospital of Xiamen University | 2025-12-01 |
| the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery (NCT07133620) | The First Affiliated Hospital of Xiamen University | 2025-11-01 |
| Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar (NCT07137052) | The First Affiliated Hospital of Xiamen University | 2025-09-30 |
| Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy (NCT07189884) | The First Affiliated Hospital of Xiamen University | 2025-09-23 |
| The Effect of Semaglutide on Bone Health (NCT07165158) | The First Affiliated Hospital of Xiamen University | 2025-09-15 |
| 68Ga-XACP3 PET/CT in Prostate Cancer (NCT07242014) | The First Affiliated Hospital of Xiamen University | 2025-09-01 |
| Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen (NCT07137039) | The First Affiliated Hospital of Xiamen University | 2025-08-20 |
| Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC (NCT07085234) | The First Affiliated Hospital of Xiamen University | 2025-07-30 |
| Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma (NCT07019181) | The First Affiliated Hospital of Xiamen University | 2025-07-30 |
| Ultrasound Assessment of Fetal Growth Parameters (NCT07018362) | The First Affiliated Hospital of Xiamen University | 2025-07-01 |
| A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer (NCT07031154) | The First Affiliated Hospital of Xiamen University | 2025-06-30 |
| Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation (NCT07034950) | The First Affiliated Hospital of Xiamen University | 2025-06-29 |
| Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care (NCT07034963) | The First Affiliated Hospital of Xiamen University | 2025-06-26 |
| T-cell Developmental Status in Patients With Malignant Hematological Tumors (NCT07035938) | The First Affiliated Hospital of Xiamen University | 2025-06-22 |
| Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC (NCT06929936) | The First Affiliated Hospital of Xiamen University | 2025-05-09 |
| Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients (NCT06956144) | The First Affiliated Hospital of Xiamen University | 2025-05-09 |
| PET/CT for Trop2 ADC Response Evaluation NSCLC (NCT07151898) | The First Affiliated Hospital of Xiamen University | 2025-05-01 |
| Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML (NCT06737523) | The First Affiliated Hospital of Xiamen University | 2025-03-15 |
| Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC (NCT06811844) | The First Affiliated Hospital of Xiamen University | 2025-02-25 |
| Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma (NCT06826118) | The First Affiliated Hospital of Xiamen University | 2025-02-08 |
| Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients (NCT06651866) | The First Affiliated Hospital of Xiamen University | 2024-12-12 |
| 68Ga-MY6349 PET/CT in Solid Tumors (NCT07046702) | The First Affiliated Hospital of Xiamen University | 2024-12-10 |
| Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer (NCT06188455) | The First Affiliated Hospital of Xiamen University | 2024-12-01 |
| IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma (NCT06688175) | The First Affiliated Hospital of Xiamen University | 2024-11-13 |
| A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment (NCT06757023) | The First Affiliated Hospital of Xiamen University | 2024-11-13 |
| SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy (NCT06676722) | The First Affiliated Hospital of Xiamen University | 2024-11-05 |
| PET/CT for Trop2 ADC Response Evaluation Cancers (NCT07046689) | The First Affiliated Hospital of Xiamen University | 2024-11-01 |
| Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL (NCT06651853) | The First Affiliated Hospital of Xiamen University | 2024-10-21 |
| A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer (NCT06696326) | The First Affiliated Hospital of Xiamen University | 2024-10-01 |
| Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma (NCT06581640) | The First Affiliated Hospital of Xiamen University | 2024-09-24 |
| Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors (NCT06584006) | The First Affiliated Hospital of Xiamen University | 2024-09-01 |
| Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy (NCT06478472) | The First Affiliated Hospital of Xiamen University | 2024-06-23 |
| ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer (NCT06465017) | The First Affiliated Hospital of Xiamen University | 2024-06-13 |
| Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression (NCT06375564) | The First Affiliated Hospital of Xiamen University | 2024-06-12 |
| A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06415669) | The First Affiliated Hospital of Xiamen University | 2024-05-19 |
| Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation. (NCT06277505) | The First Affiliated Hospital of Xiamen University | 2024-05-01 |
| Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance (NCT06281561) | The First Affiliated Hospital of Xiamen University | 2024-05-01 |
| To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer (NCT06385847) | The First Affiliated Hospital of Xiamen University | 2024-05-01 |
| Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06377683) | The First Affiliated Hospital of Xiamen University | 2024-04-05 |
| Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) (NCT06387056) | The First Affiliated Hospital of Xiamen University | 2024-04-01 |
| Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma (NCT06553352) | The First Affiliated Hospital of Xiamen University | 2024-03-31 |
| 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients (NCT07139054) | The First Affiliated Hospital of Xiamen University | 2024-01-31 |
| Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery (NCT06282224) | The First Affiliated Hospital of Xiamen University | 2024-01-22 |
| Effect of Oliceridine on Rebound Pain (NCT06382896) | The First Affiliated Hospital of Xiamen University | 2024-01-01 |
| 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis. (NCT06151119) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| AZA Combined With RCHOP in P53-mutated DLBCL. (NCT06158399) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL (NCT06151080) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma (NCT06158386) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma (NCT06158412) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma (NCT06151106) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma (NCT05970666) | The First Affiliated Hospital of Xiamen University | 2023-11-15 |
| Graves' Disease Remission Study: MycoMeth Combo (NCT06068179) | The First Affiliated Hospital of Xiamen University | 2023-10-16 |
| ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors (NCT06188468) | The First Affiliated Hospital of Xiamen University | 2023-10-01 |
| Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN) (NCT05841615) | The First Affiliated Hospital of Xiamen University | 2023-09-01 |
| Characterizing Myositis With 68Ga-FAPI PET/CT (NCT05952531) | The First Affiliated Hospital of Xiamen University | 2023-07-01 |
| Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT (NCT05999643) | The First Affiliated Hospital of Xiamen University | 2023-07-01 |
| 68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers (NCT06754345) | The First Affiliated Hospital of Xiamen University | 2023-05-30 |
| 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG (NCT05873777) | The First Affiliated Hospital of Xiamen University | 2023-04-09 |
| Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic Patients (NCT06147752) | The First Affiliated Hospital of Xiamen University | 2023-03-28 |
| VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05603884) | The First Affiliated Hospital of Xiamen University | 2022-12-01 |
| Individualized Precision Treatment Based on Ovarian Cancer Organoid Model (NCT05813509) | The First Affiliated Hospital of Xiamen University | 2022-12-01 |
| 68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers (NCT05346276) | The First Affiliated Hospital of Xiamen University | 2022-10-10 |
| APA on Sleep Quality in Women With PCOS (NCT06009172) | The First Affiliated Hospital of Xiamen University | 2022-07-24 |
| Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML (NCT06827899) | The First Affiliated Hospital of Xiamen University | 2022-07-01 |
| 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG (NCT05543317) | The First Affiliated Hospital of Xiamen University | 2022-07-01 |
| Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer (NCT05410821) | The First Affiliated Hospital of Xiamen University | 2022-06-15 |
| Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors (NCT05410743) | The First Affiliated Hospital of Xiamen University | 2022-06-01 |
| Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT (NCT05430841) | The First Affiliated Hospital of Xiamen University | 2022-06-01 |
| A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer (NCT05824247) | The First Affiliated Hospital of Xiamen University | 2022-04-01 |
| Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC (NCT05292417) | The First Affiliated Hospital of Xiamen University | 2022-03-25 |
| Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients (NCT05424393) | The First Affiliated Hospital of Xiamen University | 2022-03-04 |
| Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer (NCT05392205) | The First Affiliated Hospital of Xiamen University | 2022-03-01 |
| Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors (NCT05963386) | The First Affiliated Hospital of Xiamen University | 2022-02-22 |
| A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy (NCT05287386) | The First Affiliated Hospital of Xiamen University | 2022-01-21 |
| Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML (NCT05305859) | The First Affiliated Hospital of Xiamen University | 2022-01-12 |
| Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy of Hepatic Lesions (NCT07249268) | The First Affiliated Hospital of Xiamen University | 2022-01-01 |
| the Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial Infarction (NCT06841549) | The First Affiliated Hospital of Xiamen University | 2021-12-03 |
| Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC (NCT05055167) | The First Affiliated Hospital of Xiamen University | 2021-08-30 |
| Prevention In Community Clinics From Diabetic Kidney Disease (NCT04988581) | The First Affiliated Hospital of Xiamen University | 2021-08-01 |
| Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer (NCT04941872) | The First Affiliated Hospital of Xiamen University | 2021-06-18 |
| Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer (NCT04840758) | The First Affiliated Hospital of Xiamen University | 2021-06-01 |
| 68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer) (NCT04849247) | The First Affiliated Hospital of Xiamen University | 2021-04-13 |
| Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC (NCT04425135) | The First Affiliated Hospital of Xiamen University | 2020-07-01 |
| 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma (NCT04588064) | The First Affiliated Hospital of Xiamen University | 2020-07-01 |
| Diabetic Complications and Obstructive Sleep Apnea (NCT04646941) | The First Affiliated Hospital of Xiamen University | 2020-06-10 |
| Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial) (NCT03802253) | The First Affiliated Hospital of Xiamen University | 2020-05-04 |
| Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer (NCT04389151) | The First Affiliated Hospital of Xiamen University | 2020-03-04 |
| Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children (NCT06530004) | The First Affiliated Hospital of Xiamen University | 2020-03-01 |
| Difference Between Mean Gestational Sac Diameter and Crown-rump Length as a Marker of First-trimester Pregnancy Outcome in Patients With Recurrent Spontaneous Abortion (NCT06081556) | The First Affiliated Hospital of Xiamen University | 2020-01-01 |